Liang Chen - Researcher Profile | RDL Research Database

Publications

2 shown

A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

Suping Li , Qiao Jiang , Shaoli Liu +16 more

2018 Nature Biotechnology 1408 citations

Suramin Therapy for Patients With Symptomatic Hormone-Refractory Prostate Cancer: Results of a Randomized Phase III Trial Comparing Suramin Plus Hydrocortisone to Placebo Plus Hydrocortisone

Eric J. Small , Mark Meyer , M. Ernest Marshall +7 more

PURPOSE: Suramin is a novel agent that has demonstrated preliminary evidence of antitumor activity in hormone-refractory prostate cancer (HRPC). A prospective randomized clinica...

2000 Journal of Clinical Oncology 188 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,596
Institution: Jinan University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-7300-6604

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.